NANOSNET

 View Only

  • 1.  GCA - NJM article

    Posted 07-26-2025 19:14

    Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis

    Authors: Matthew J. Koster, M.D., and Kenneth J. Warrington, M.D. https://orcid.org/0000-0001-7708-2487Author Info & Affiliations
    Published May 28, 2025
    N Engl J Med 2025;392:2062-2064
    DOI: 10.1056/NEJMe2503584
    Copyright © 2025 


    Edward M. Cohn, MD, mba, mph
    3535 W. 13 Mile (506)
    Royal Oak, MI 48073
    Ph: 248-551-8282
    Fax: 248-551-9085




  • 2.  RE: GCA - NJM article

    Posted 08-28-2025 13:49

    Thank you Dr Cohn for posting this.

    Any experience with upadacitinib (Rinvoq) for GCA? I just saw a patient who was started on it by their rheumatologist. 

    Manasa. 



    ------------------------------
    Manasa Gunturu MD
    Associate Professor
    University of Mississippi Medical Center (UMMC)
    ------------------------------

    Original Message


  • 3.  RE: GCA - NJM article

    Posted 09-01-2025 11:45
    I have no more knowledge than what is in the NEJM 

    It was news to me. - Just sharing 

    We are entering a new world in healthcare.


    Edward M. Cohn, MD, mba, mph
    3535 W. 13 Mile (506)
    Royal Oak, MI  48073
    Ph: 248-551-8282
    Fax: 248-551-9085




    Original Message


Related Content